Descrizione

Metabolomics is an analytical profiling technique for measuring and comparing large numbers of metabolites present in biological samples. Combining high-throughput analytical chemistry and multivariate data analysis, metabolomics offers a window on metabolic mechanisms. The global metabolomics market is poised to grow by US$ 12.1 miliardi durante 2022-2028, procedendo a un CAGR di 11.8% durante il periodo di previsione, secondo la società di dati e analisi StrategyHelix.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2018-2021 e previsione a 2028 covering key market aspects like sales value for metabolomics. The global metabolomics market is segmented on the basis of product, indication, applicazione, e regione. Per prodotto, the global metabolomics market has been segmented into assays, bioinformatics, detection techniques, separation techniques. The separation techniques segment was the largest contributor to the global metabolomics market in 2021. Based upon indication, the global metabolomics market is categorized into cancer, cardiovascular disorders, inborn errors of metabolism, neurological disorders, altri. Secondo la ricerca, the cancer segment had the largest share in the global metabolomics market. On the basis of application, the global metabolomics market has been segmented into biomarker discovery, drug discovery, functional genomics, nutrigenomics, toxicology testing, altri. The biomarker discovery segment held the largest revenue share in 2021. Geograficamente, the global metabolomics market is segmented into Asia Pacific, Europa, Nord America, COSA (Medio Oriente e Africa), America Latina. Globally, North America made up the largest share of the metabolomics market.

The separation techniques market is further segmented into capillary electrophoresis, gas chromatography, and liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography). The liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography) segment is estimated to account for the largest share of the global metabolomics market. Inoltre, the detection techniques market has been categorized into mass spectrometry, multivariate analysis, and spectroscopy (NMR and FTIR). The mass spectrometry segment held the largest share of the global metabolomics market in 2021 e si prevede che manterrà la sua quota durante il periodo di previsione.

The global metabolomics market is highly competitive. The report also includes the profiles of leading companies such as Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, LECO Corporation, Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation.

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the metabolomics market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Prodotto: assays, bioinformatics, detection techniques, separation techniques
Indication: cancer, cardiovascular disorders, inborn errors of metabolism, neurological disorders, altri
Applicazione: biomarker discovery, drug discovery, functional genomics, nutrigenomics, toxicology testing, altri
Regione: Asia Pacifico, Europa, Nord America, COSA (Medio Oriente e Africa), America Latina
Anni considerati: la presente relazione copre il periodo 2018 A 2028

Principali vantaggi per gli stakeholder

– Get a comprehensive picture of the global metabolomics market
– Individuare i settori in crescita e le tendenze per gli investimenti

Sommario

Parte 1. introduzione
– Ambito dello studio
– Periodo di studio
– Ambito geografico
– Metodologia di ricerca
Parte 2. Metabolomics market overview
Parte 3. Ripartizione del mercato per prodotto
– Assays
– Bioinformatics
– Detection techniques
– Separation techniques
Parte 4. Market breakdown by indication
– Cancer
– Cardiovascular disorders
– Inborn errors of metabolism
– Neurological disorders
– Altri
Parte 5. Market breakdown by application
– Biomarker discovery
– Drug discovery
– Functional genomics
– Nutrigenomics
– Toxicology testing
– Altri
Parte 6. Market breakdown by region
– Asia Pacifico
– Europa
– Nord America
– COSA (Medio Oriente e Africa)
– America Latina
Parte 7. Aziende chiave
– Agilent Technologies Inc.
– Bio-Rad Laboratories Inc.
– Bruker Corporation
– Danaher Corporation
– LECO Corporation
– Metabolon Inc.
– Shimadzu Corporation
– Thermo Fisher Scientific Inc.
– Waters Corporation
Informazioni su StrategyHelix
Disclaimer